| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.636 | 0.011 | 0.774 | 5 Hydroxytryptamine release stimulant | 0.774 0.004 DBMET00940 | DBMET00940 | |
| 0.578 | 0.008 | 0.578 | Anticonvulsant | 0.425 0.019 DBMET00940 | ||
| 0.547 | 0.003 | 0.547 | Dopamine D2 agonist | 0.538 0.004 DBMET00940 | ||
| 0.542 | 0.008 | 0.542 | Psychostimulant | 0.498 0.011 DBMET00940 | ||
| 0.519 | 0.004 | 0.519 | Dopamine agonist | 0.503 0.004 DBMET00940 | ||
| 0.515 | 0.014 | 0.515 | Cardiotonic | 0.338 0.043 DBMET00940 | ||
| 0.485 | 0.008 | 0.485 | Cyclic AMP phosphodiesterase inhibitor | 0.281 0.05 DBMET00940 | ||
| 0.461 | 0.037 | 0.506 | Vasodilator, peripheral | 0.506 0.027 DBMET00940 | DBMET00940 | |
| 0.413 | 0.021 | 0.413 | Vasodilator | 0.352 0.033 DBMET00940 | ||
| 0.389 | 0.007 | 0.389 | 5 Hydroxytryptamine 1 antagonist | 0.309 0.009 DBMET00940 | ||
| 0.435 | 0.059 | 0.443 | Calcium channel L-type activator | 0.443 0.055 DBMET00940 | DBMET00940 | |
| 0.367 | 0.007 | 0.367 | 5 Hydroxytryptamine 1A antagonist | 0.299 0.009 DBMET00940 | ||
| 0.353 | 0.004 | 0.353 | 5 Hydroxytryptamine 1D antagonist | 0.174 0.009 DBMET00940 | ||
| 0.389 | 0.042 | 0.389 | Spasmolytic | 0.252 0.09 DBMET00940 | ||
| 0.347 | 0.004 | 0.347 | 5 Hydroxytryptamine 1B antagonist | 0.189 0.009 DBMET00940 | ||
| 0.343 | 0.005 | 0.343 | 5 Hydroxytryptamine 1F antagonist | 0.169 0.014 DBMET00940 | ||
| 0.37 | 0.038 | 0.37 | Calcium channel activator | 0.359 0.044 DBMET00940 | ||
| 0.391 | 0.066 | 0.403 | GABA C receptor rho-3 antagonist | 0.403 0.06 DBMET00940 | DBMET00940 | |
| 0.322 | 0.005 | 0.358 | NMDA receptor antagonist | 0.358 0.005 DBMET00940 | DBMET00940 | |
| 0.363 | 0.049 | 0.363 | Vasodilator, coronary | 0.328 0.067 DBMET00940 | ||
| 0.323 | 0.009 | 0.323 | Dopamine D2 antagonist | 0.208 0.016 DBMET00940 | ||
| 0.323 | 0.024 | 0.323 | Tyrosine 3 hydroxylase inhibitor | 0.289 0.039 DBMET00940 | ||
| 0.315 | 0.017 | 0.315 | 5 Hydroxytryptamine antagonist | 0.229 0.028 DBMET00940 | ||
| 0.333 | 0.041 | 0.333 | Insulysin inhibitor | 0.293 0.063 DBMET00940 | ||
| 0.283 | 0.003 | 0.283 | 5 Hydroxytryptamine 2A agonist | 0.235 0.004 DBMET00940 | ||
| 0.389 | 0.111 | 0.422 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.422 0.082 DBMET00940 | DBMET00940 | |
| 0.289 | 0.012 | 0.289 | Dopamine antagonist | 0.19 0.02 DBMET00940 | ||
| 0.286 | 0.01 | 0.286 | Alpha 2b adrenoreceptor antagonist | 0.218 0.02 DBMET00940 | ||
| 0.278 | 0.004 | 0.278 | 5 Hydroxytryptamine 5A antagonist | 0.143 0.008 DBMET00940 | ||
| 0.273 | 0.009 | 0.273 | 5 Hydroxytryptamine agonist | 0.203 0.014 DBMET00940 | ||
| 0.26 | 0.002 | 0.26 | Glycine receptor antagonist | 0.18 0.004 DBMET00940 | ||
| 0.26 | 0.004 | 0.26 | Prolactin inhibitor | 0.151 0.022 DBMET00940 | ||
| 0.261 | 0.008 | 0.261 | 5 Hydroxytryptamine 1 agonist | 0.195 0.011 DBMET00940 | ||
| 0.271 | 0.02 | 0.271 | Acetylcholine M1 receptor antagonist | 0.242 0.027 DBMET00940 | ||
| 0.276 | 0.025 | 0.276 | Focal adhesion kinase 2 inhibitor | 0.217 0.057 DBMET00940 | ||
| 0.248 | 0.004 | 0.248 | 5 Hydroxytryptamine 5 antagonist | 0.136 0.009 DBMET00940 | ||
| 0.272 | 0.041 | 0.272 | Anesthetic general | 0.148 0.116 DBMET00940 | ||
| 0.346 | 0.118 | 0.346 | 5 Hydroxytryptamine release inhibitor | 0.291 0.175 DBMET00940 | ||
| 0.275 | 0.049 | 0.275 | 5 Hydroxytryptamine 1E antagonist | 0.249 0.076 DBMET00940 | ||
| 0.222 | 0.003 | 0.222 | AMPA 4 receptor antagonist | 0.165 0.004 DBMET00940 | ||
| 0.243 | 0.036 | 0.243 | Lipocortins synthesis antagonist | 0.175 0.076 DBMET00940 | ||
| 0.229 | 0.022 | 0.229 | 5 Hydroxytryptamine 2B antagonist | 0.124 0.056 DBMET00940 | ||
| 0.23 | 0.024 | 0.23 | 5 Hydroxytryptamine 2 antagonist | 0.16 0.041 DBMET00940 | ||
| 0.213 | 0.015 | 0.213 | Alpha 2c adrenoreceptor antagonist | 0.18 0.022 DBMET00940 | ||
| 0.227 | 0.03 | 0.227 | 5 Hydroxytryptamine 3E antagonist | 0.224 0.033 DBMET00940 | ||
| 0.198 | 0.006 | 0.198 | Cyclin B3 inhibitor | 0.192 0.007 DBMET00940 | ||
| 0.195 | 0.003 | 0.195 | Dopamine autoreceptor agonist | 0.137 0.004 DBMET00940 | ||
| 0.232 | 0.051 | 0.232 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.207 0.067 DBMET00940 | ||
| 0.2 | 0.019 | 0.2 | Nav1.6 sodium channel blocker | 0.149 0.055 DBMET00940 | ||
| 0.18 | 0.003 | 0.18 | Kainate receptor 2 antagonist | 0.139 0.004 DBMET00940 | ||
| 0.214 | 0.038 | 0.214 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.142 0.066 DBMET00940 | ||
| 0.206 | 0.03 | 0.206 | Death-associated protein kinase 2 inhibitor | 0.183 0.05 DBMET00940 | ||
| 0.228 | 0.052 | 0.228 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.194 0.067 DBMET00940 | ||
| 0.187 | 0.016 | 0.187 | Alpha 2a adrenoreceptor antagonist | 0.133 0.026 DBMET00940 | ||
| 0.238 | 0.068 | 0.238 | Neuropeptide Y2 antagonist | 0.227 0.08 DBMET00940 | ||
| 0.21 | 0.043 | 0.21 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.165 0.058 DBMET00940 | ||
| 0.267 | 0.1 | 0.299 | Interleukin 2 agonist | 0.299 0.074 DBMET00940 | DBMET00940 | |
| 0.193 | 0.028 | 0.215 | Glutamate receptor antagonist | 0.215 0.022 DBMET00940 | DBMET00940 | |
| 0.191 | 0.027 | 0.191 | Acetylcholine muscarinic antagonist | 0.173 0.033 DBMET00940 | ||
| 0.191 | 0.029 | 0.191 | Alpha adrenoreceptor antagonist | 0.176 0.031 DBMET00940 | ||
| 0.191 | 0.04 | 0.218 | Neurotensin receptor agonist | 0.218 0.028 DBMET00940 | DBMET00940 | |
| 0.241 | 0.09 | 0.25 | Gastrin inhibitor | 0.25 0.08 DBMET00940 | DBMET00940 | |
| 0.169 | 0.018 | 0.169 | Calcium antagonist | 0.13 0.03 DBMET00940 | ||
| 0.215 | 0.066 | 0.262 | Nitric-oxide synthase stimulant | 0.262 0.025 DBMET00940 | DBMET00940 | |
| 0.158 | 0.009 | 0.158 | Acetylcholine M4 receptor antagonist | 0.108 0.023 DBMET00940 | ||
| 0.172 | 0.024 | 0.172 | 5 Hydroxytryptamine 2A antagonist | 0.12 0.038 DBMET00940 | ||
| 0.183 | 0.041 | 0.183 | Nav1.2 sodium channel blocker | 0.134 0.068 DBMET00940 | ||
| 0.171 | 0.03 | 0.299 | Antiadrenergic | 0.299 0.014 DBMET00940 | DBMET00940 | |
| 0.23 | 0.09 | 0.23 | Aldehyde oxidase inhibitor | |||
| 0.209 | 0.07 | 0.209 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.198 0.078 DBMET00940 | ||
| 0.144 | 0.004 | 0.144 | 5 Hydroxytryptamine 1B agonist | 0.109 0.005 DBMET00940 | ||
| 0.145 | 0.007 | 0.145 | NMDA receptor subunit 3B antagonist | 0.131 0.008 DBMET00940 | ||
| 0.158 | 0.02 | 0.158 | Alpha 1b adrenoreceptor antagonist | 0.148 0.022 DBMET00940 | ||
| 0.148 | 0.011 | 0.148 | Sigma receptor antagonist | 0.051 0.034 DBMET00940 | ||
| 0.167 | 0.032 | 0.167 | Cyclin-dependent kinase 5 inhibitor | 0.154 0.038 DBMET00940 | ||
| 0.164 | 0.031 | 0.296 | Adrenaline antagonist | 0.296 0.013 DBMET00940 | DBMET00940 | |
| 0.148 | 0.015 | 0.148 | Dopamine D3 antagonist | 0.113 0.021 DBMET00940 | ||
| 0.139 | 0.007 | 0.16 | Beta 3 adrenoreceptor antagonist | 0.16 0.005 DBMET00940 | DBMET00940 | |
| 0.253 | 0.123 | 0.253 | Antithrombotic | 0.204 0.172 DBMET00940 | ||
| 0.137 | 0.008 | 0.147 | NMDA 2C receptor antagonist | 0.147 0.007 DBMET00940 | DBMET00940 | |
| 0.145 | 0.016 | 0.242 | Adrenaline agonist | 0.242 0.005 DBMET00940 | DBMET00940 | |
| 0.23 | 0.103 | 0.232 | 5 Hydroxytryptamine uptake stimulant | 0.232 0.101 DBMET00940 | DBMET00940 | |
| 0.16 | 0.034 | 0.16 | Ferrochelatase inhibitor | 0.138 0.043 DBMET00940 | ||
| 0.152 | 0.027 | 0.152 | Alpha 2 adrenoreceptor antagonist | 0.105 0.044 DBMET00940 | ||
| 0.151 | 0.026 | 0.151 | 5 Hydroxytryptamine 2C antagonist | 0.118 0.037 DBMET00940 | ||
| 0.168 | 0.043 | 0.168 | Cholinergic antagonist | 0.146 0.055 DBMET00940 | ||
| 0.14 | 0.019 | 0.208 | NMDA 2 receptor antagonist | 0.208 0.009 DBMET00940 | DBMET00940 | |
| 0.164 | 0.043 | 0.164 | Acetylcholine antagonist | 0.144 0.053 DBMET00940 | ||
| 0.139 | 0.019 | 0.139 | Histamine N-methyltransferase inhibitor | |||
| 0.149 | 0.031 | 0.149 | Photosensitizer | 0.133 0.043 DBMET00940 | ||
| 0.176 | 0.058 | 0.176 | Cholinergic | 0.131 0.094 DBMET00940 | ||
| 0.148 | 0.031 | 0.148 | GABA C receptor antagonist | 0.144 0.033 DBMET00940 | ||
| 0.127 | 0.011 | 0.132 | Acetylcholine M5 receptor antagonist | 0.132 0.01 DBMET00940 | DBMET00940 | |
| 0.261 | 0.147 | 0.261 | Histamine release inhibitor | |||
| 0.134 | 0.019 | 0.134 | Dopamine D4 antagonist | 0.123 0.021 DBMET00940 | ||
| 0.162 | 0.048 | 0.162 | Acetylcholinesterase inhibitor | 0.131 0.069 DBMET00940 | ||
| 0.144 | 0.03 | 0.154 | Alpha 1 adrenoreceptor antagonist | 0.154 0.029 DBMET00940 | DBMET00940 | |
| 0.158 | 0.045 | 0.158 | Anesthetic local | 0.093 0.09 DBMET00940 | ||
| 0.192 | 0.08 | 0.192 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.157 0.105 DBMET00940 | ||
| 0.12 | 0.01 | 0.164 | Beta adrenoreceptor antagonist | 0.164 0.005 DBMET00940 | DBMET00940 | |
| 0.119 | 0.01 | 0.186 | NMDA 2A receptor antagonist | 0.186 0.005 DBMET00940 | DBMET00940 | |
| 0.117 | 0.007 | 0.117 | 5 Hydroxytryptamine 2 agonist | 0.088 0.012 DBMET00940 | ||
| 0.143 | 0.036 | 0.143 | Protein kinase C gamma inhibitor | 0.13 0.044 DBMET00940 | ||
| 0.111 | 0.005 | 0.149 | AMPA 1 receptor antagonist | 0.149 0.004 DBMET00940 | DBMET00940 | |
| 0.112 | 0.008 | 0.167 | Beta 1 adrenoreceptor antagonist | 0.167 0.004 DBMET00940 | DBMET00940 | |
| 0.107 | 0.004 | 0.14 | AMPA 3 receptor antagonist | 0.14 0.004 DBMET00940 | DBMET00940 | |
| 0.11 | 0.01 | 0.142 | AMPA receptor antagonist | 0.142 0.006 DBMET00940 | DBMET00940 | |
| 0.161 | 0.06 | 0.172 | GABA C receptor rho-2 antagonist | 0.172 0.049 DBMET00940 | DBMET00940 | |
| 0.155 | 0.055 | 0.179 | Adenylate cyclase stimulant | 0.179 0.026 DBMET00940 | DBMET00940 | |
| 0.199 | 0.101 | 0.199 | RNA-directed DNA polymerase inhibitor | 0.186 0.122 DBMET00940 | ||
| 0.152 | 0.057 | 0.152 | Calcium channel blocker | 0.11 0.099 DBMET00940 | ||
| 0.116 | 0.022 | 0.129 | Myeloperoxidase inhibitor | 0.129 0.016 DBMET00940 | DBMET00940 | |
| 0.294 | 0.2 | 0.294 | Caspase 9 stimulant | |||
| 0.1 | 0.007 | 0.105 | Dopamine D3 agonist | 0.105 0.006 DBMET00940 | DBMET00940 | |
| 0.1 | 0.007 | 0.1 | 5 Hydroxytryptamine 7 agonist | 0.074 0.016 DBMET00940 | ||
| 0.109 | 0.019 | 0.109 | Acetylcholine M2 receptor antagonist | 0.093 0.023 DBMET00940 | ||
| 0.109 | 0.02 | 0.109 | Calcium channel L-type blocker | 0.076 0.044 DBMET00940 | ||
| 0.124 | 0.035 | 0.162 | Nitric-oxide synthase inhibitor | 0.162 0.018 DBMET00940 | DBMET00940 | |
| 0.092 | 0.004 | 0.092 | Kainate receptor 4 antagonist | 0.054 0.006 DBMET00940 | ||
| 0.163 | 0.077 | 0.163 | Sigma receptor agonist | |||
| 0.138 | 0.053 | 0.142 | Vanilloid 1 agonist | 0.142 0.047 DBMET00940 | DBMET00940 | |
| 0.094 | 0.008 | 0.094 | Kainate receptor antagonist | 0.088 0.009 DBMET00940 | ||
| 0.118 | 0.033 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.193 | 0.109 | 0.258 | Peptidyltransferase inhibitor | 0.258 0.045 DBMET00940 | DBMET00940 | |
| 0.088 | 0.006 | 0.11 | AMPA 2 receptor antagonist | 0.11 0.005 DBMET00940 | DBMET00940 | |
| 0.145 | 0.063 | 0.145 | Pregnane X receptor agonist | |||
| 0.089 | 0.009 | 0.153 | Beta 2 adrenoreceptor antagonist | 0.153 0.004 DBMET00940 | DBMET00940 | |
| 0.084 | 0.005 | 0.084 | 5 Hydroxytryptamine 1D agonist | 0.062 0.007 DBMET00940 | ||
| 0.089 | 0.011 | 0.089 | Cyclin B2 inhibitor | 0.086 0.012 DBMET00940 | ||
| 0.127 | 0.049 | 0.127 | MAO A inhibitor | 0.098 0.066 DBMET00940 | ||
| 0.096 | 0.019 | 0.105 | Acetylcholine M3 receptor antagonist | 0.105 0.017 DBMET00940 | DBMET00940 | |
| 0.109 | 0.033 | 0.121 | Alpha 1a adrenoreceptor antagonist | 0.121 0.029 DBMET00940 | DBMET00940 | |
| 0.09 | 0.015 | 0.09 | Cyclin B1 inhibitor | 0.088 0.016 DBMET00940 | ||
| 0.08 | 0.005 | 0.08 | 5 Hydroxytryptamine 2B agonist | 0.05 0.013 DBMET00940 | ||
| 0.176 | 0.101 | 0.176 | Platelet aggregation inhibitor | 0.142 0.138 DBMET00940 | ||
| 0.084 | 0.01 | 0.084 | NMDA receptor subunit 3A antagonist | 0.084 0.01 DBMET00940 | ||
| 0.076 | 0.005 | 0.165 | Melatonin antagonist | 0.165 0.004 DBMET00940 | DBMET00940 | |
| 0.096 | 0.026 | 0.096 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.129 | 0.06 | 0.134 | Adenylate cyclase inhibitor | 0.134 0.057 DBMET00940 | DBMET00940 | |
| 0.147 | 0.078 | 0.147 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.132 0.111 DBMET00940 | ||
| 0.134 | 0.068 | 0.134 | Toll-Like receptor antagonist | |||
| 0.091 | 0.026 | 0.093 | Alpha 1d adrenoreceptor antagonist | 0.093 0.025 DBMET00940 | DBMET00940 | |
| 0.094 | 0.03 | 0.094 | CC chemokine 5 receptor agonist | 0.079 0.067 DBMET00940 | ||
| 0.079 | 0.016 | 0.079 | Cyclin B inhibitor | 0.077 0.017 DBMET00940 | ||
| 0.075 | 0.013 | 0.093 | Beta 2 adrenoreceptor agonist | 0.093 0.005 DBMET00940 | DBMET00940 | |
| 0.08 | 0.017 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | 0.074 0.023 DBMET00940 | ||
| 0.066 | 0.004 | 0.066 | Kainate receptor 1 antagonist | 0.041 0.007 DBMET00940 | ||
| 0.118 | 0.056 | 0.118 | Cyclin-dependent kinase 1 inhibitor | 0.085 0.078 DBMET00940 | ||
| 0.135 | 0.074 | 0.135 | Neurotrophic factor | 0.119 0.096 DBMET00940 | ||
| 0.066 | 0.005 | 0.066 | Kainate receptor 5 antagonist | 0.031 0.009 DBMET00940 | ||
| 0.097 | 0.036 | 0.097 | Somatostatin 1 agonist | 0.088 0.043 DBMET00940 | ||
| 0.075 | 0.015 | 0.077 | Epithelial sodium channel blocker | 0.077 0.014 DBMET00940 | DBMET00940 | |
| 0.066 | 0.006 | 0.197 | Melatonin agonist | 0.197 0.004 DBMET00940 | DBMET00940 | |
| 0.109 | 0.05 | 0.109 | Sphingomyelinase inhibitor | |||
| 0.086 | 0.027 | 0.086 | Phospholipase D inhibitor | 0.076 0.041 DBMET00940 | ||
| 0.071 | 0.014 | 0.071 | 5 Hydroxytryptamine 2C agonist | 0.06 0.021 DBMET00940 | ||
| 0.08 | 0.024 | 0.08 | Androgen agonist | 0.063 0.037 DBMET00940 | ||
| 0.066 | 0.009 | 0.066 | Benzodiazepine antagonist | 0.045 0.04 DBMET00940 | ||
| 0.101 | 0.044 | 0.106 | Acetylcholine M3 receptor agonist | 0.106 0.042 DBMET00940 | DBMET00940 | |
| 0.135 | 0.079 | 0.135 | Lipid peroxidase inhibitor | 0.126 0.088 DBMET00940 | ||
| 0.098 | 0.042 | 0.098 | Histamine H1 receptor antagonist | 0.074 0.064 DBMET00940 | ||
| 0.1 | 0.046 | 0.1 | Polo-like kinase-1 inhibitor | 0.086 0.069 DBMET00940 | ||
| 0.116 | 0.062 | 0.116 | Calcium channel (voltage-sensitive) blocker | |||
| 0.124 | 0.072 | 0.124 | MAO inhibitor | |||
| 0.204 | 0.153 | 0.207 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.207 0.149 DBMET00940 | DBMET00940 | |
| 0.105 | 0.055 | 0.127 | GABA C receptor rho-1 antagonist | 0.127 0.034 DBMET00940 | DBMET00940 | |
| 0.08 | 0.033 | 0.08 | Dopamine D1 antagonist | |||
| 0.105 | 0.058 | 0.105 | Butyrylcholinesterase inhibitor | 0.099 0.063 DBMET00940 | ||
| 0.108 | 0.061 | 0.108 | Mediator release inhibitor | |||
| 0.05 | 0.004 | 0.05 | Kainate receptor 3 antagonist | 0.024 0.007 DBMET00940 | ||
| 0.052 | 0.007 | 0.087 | Melatonin receptor 1A agonist | 0.087 0.004 DBMET00940 | DBMET00940 | |
| 0.052 | 0.009 | 0.106 | Melatonin 1 agonist | 0.106 0.004 DBMET00940 | DBMET00940 | |
| 0.09 | 0.047 | 0.096 | Histamine H2 receptor antagonist | 0.096 0.039 DBMET00940 | DBMET00940 | |
| 0.056 | 0.014 | 0.056 | Plasmepsin II inhibitor | 0.038 0.036 DBMET00940 | ||
| 0.147 | 0.106 | 0.147 | ATPase inhibitor | |||
| 0.064 | 0.024 | 0.064 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.218 | 0.178 | 0.224 | Immunosuppressant | 0.224 0.172 DBMET00940 | DBMET00940 | |
| 0.079 | 0.04 | 0.079 | Benzodiazepine agonist | |||
| 0.047 | 0.008 | 0.047 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.084 | 0.045 | 0.084 | Interferon agonist | 0.076 0.058 DBMET00940 | ||
| 0.102 | 0.064 | 0.102 | Nav1.1 sodium channel blocker | |||
| 0.067 | 0.029 | 0.067 | Acetylcholine muscarinic agonist | |||
| 0.048 | 0.01 | 0.048 | Sigma 1 receptor antagonist | |||
| 0.089 | 0.051 | 0.103 | Hematopoietic | 0.103 0.033 DBMET00940 | DBMET00940 | |
| 0.056 | 0.019 | 0.056 | Oxytocin agonist | 0.051 0.023 DBMET00940 | ||
| 0.098 | 0.061 | 0.098 | Electrolyte absorption antagonist | |||
| 0.101 | 0.065 | 0.101 | Gastric antisecretory | 0.099 0.067 DBMET00940 | ||
| 0.107 | 0.072 | 0.116 | Acetylcholine release stimulant | 0.116 0.054 DBMET00940 | DBMET00940 | |
| 0.054 | 0.02 | 0.054 | Purinergic P2X4 antagonist | 0.051 0.024 DBMET00940 | ||
| 0.05 | 0.016 | 0.062 | Histone deacetylase 9 inhibitor | 0.062 0.011 DBMET00940 | DBMET00940 | |
| 0.056 | 0.023 | 0.056 | Acetylcholine M1 receptor agonist | |||
| 0.058 | 0.025 | 0.058 | Vanilloid 2 antagonist | |||
| 0.075 | 0.042 | 0.105 | Alpha adrenoreceptor agonist | 0.105 0.026 DBMET00940 | DBMET00940 | |
| 0.05 | 0.018 | 0.071 | Beta adrenoreceptor agonist | 0.071 0.005 DBMET00940 | DBMET00940 | |
| 0.052 | 0.02 | 0.052 | Neuraminidase (Influenza A) inhibitor | |||
| 0.088 | 0.056 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.07 DBMET00940 | ||
| 0.069 | 0.037 | 0.094 | NMDA receptor agonist | 0.094 0.021 DBMET00940 | DBMET00940 | |
| 0.113 | 0.082 | 0.113 | Nav1.3 sodium channel blocker | |||
| 0.044 | 0.013 | 0.117 | Melatonin 2 agonist | 0.117 0.004 DBMET00940 | DBMET00940 | |
| 0.07 | 0.04 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.056 | 0.026 | 0.087 | 5 Hydroxytryptamine 1A agonist | 0.087 0.018 DBMET00940 | DBMET00940 | |
| 0.133 | 0.104 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.13 0.119 DBMET00940 | ||
| 0.035 | 0.006 | 0.096 | Melatonin 1 antagonist | 0.096 0.004 DBMET00940 | DBMET00940 | |
| 0.048 | 0.019 | 0.073 | Histone deacetylase 7 inhibitor | 0.073 0.012 DBMET00940 | DBMET00940 | |
| 0.065 | 0.037 | 0.065 | Alpha 2 adrenoreceptor agonist | 0.054 0.051 DBMET00940 | ||
| 0.076 | 0.048 | 0.098 | Cathepsin G inhibitor | 0.098 0.034 DBMET00940 | DBMET00940 | |
| 0.052 | 0.024 | 0.073 | Adenylate cyclase 1 inhibitor | 0.073 0.011 DBMET00940 | DBMET00940 | |
| 0.097 | 0.07 | 0.097 | GABA C receptor agonist | 0.097 0.07 DBMET00940 | ||
| 0.11 | 0.083 | 0.11 | Aldehyde dehydrogenase inhibitor | 0.108 0.086 DBMET00940 | ||
| 0.063 | 0.036 | 0.127 | Glutamate (mGluR1) antagonist | 0.127 0.01 DBMET00940 | DBMET00940 | |
| 0.086 | 0.059 | 0.086 | Acetylcholine agonist | |||
| 0.086 | 0.059 | 0.086 | Androgen antagonist | 0.078 0.068 DBMET00940 | ||
| 0.101 | 0.076 | 0.101 | Chelator | 0.093 0.087 DBMET00940 | ||
| 0.043 | 0.019 | 0.043 | Nociceptin (N/OFQ) receptor antagonist | 0.039 0.022 DBMET00940 | ||
| 0.173 | 0.151 | 0.203 | Superoxide dismutase inhibitor | 0.203 0.114 DBMET00940 | DBMET00940 | |
| 0.079 | 0.06 | 0.08 | Opioid kappa receptor antagonist | 0.08 0.058 DBMET00940 | DBMET00940 | |
| 0.024 | 0.005 | 0.071 | Melatonin receptor 1A antagonist | 0.071 0.003 DBMET00940 | DBMET00940 | |
| 0.145 | 0.126 | 0.145 | MAP kinase kinase 2 inhibitor | |||
| 0.087 | 0.069 | 0.087 | MAO B inhibitor | |||
| 0.097 | 0.079 | 0.125 | 5 Hydroxytryptamine 3A agonist | 0.125 0.052 DBMET00940 | DBMET00940 | |
| 0.067 | 0.049 | 0.067 | MDM2 inhibitor | 0.067 0.049 DBMET00940 | ||
| 0.045 | 0.028 | 0.062 | Histamine H1 receptor agonist | 0.062 0.007 DBMET00940 | DBMET00940 | |
| 0.083 | 0.066 | 0.085 | Opioid antagonist | 0.085 0.062 DBMET00940 | DBMET00940 | |
| 0.073 | 0.057 | 0.073 | Analgesic, opioid | 0.069 0.063 DBMET00940 | ||
| 0.052 | 0.035 | 0.052 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.028 | 0.012 | 0.036 | Acid ceramidase inhibitor | 0.036 0.005 DBMET00940 | DBMET00940 | |
| 0.076 | 0.061 | 0.076 | Platelet growth factor antagonist | |||
| 0.058 | 0.044 | 0.058 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.08 | 0.067 | 0.09 | Estrogen-related receptor beta agonist | 0.09 0.041 DBMET00940 | DBMET00940 | |
| 0.028 | 0.017 | 0.028 | Urotensin II agonist | |||
| 0.19 | 0.179 | 0.212 | Transcription factor NF kappa B inhibitor | 0.212 0.157 DBMET00940 | DBMET00940 | |
| 0.07 | 0.059 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 DBMET00940 | DBMET00940 | |
| 0.036 | 0.026 | 0.036 | Kinesin-like protein 1 inhibitor | |||
| 0.036 | 0.026 | 0.036 | Kinesin antagonist | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.039 | 0.03 | 0.039 | CDK5/p25 inhibitor | |||
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.053 | 0.045 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.021 | 0.013 | 0.021 | Toll-Like receptor 8 agonist | |||
| 0.036 | 0.029 | 0.039 | Cholecystokinin B agonist | 0.039 0.024 DBMET00940 | DBMET00940 | |
| 0.082 | 0.075 | 0.082 | Antihistaminic | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.025 | 0.018 | 0.025 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.065 | 0.059 | 0.065 | Protein kinase C beta inhibitor | |||
| 0.025 | 0.02 | 0.025 | Sigma 2 receptor antagonist | |||
| 0.041 | 0.036 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.091 | 0.086 | 0.091 | Adenylate kinase inhibitor | |||
| 0.034 | 0.03 | 0.034 | Factor XIIIa inhibitor | |||
| 0.076 | 0.072 | 0.079 | Caspase 7 inhibitor | 0.079 0.063 DBMET00940 | DBMET00940 | |
| 0.081 | 0.078 | 0.081 | Alcohol dehydrogenase inhibitor | |||
| 0.059 | 0.056 | 0.059 | Interferon inducer | |||
| 0.078 | 0.075 | 0.078 | Vanilloid agonist | |||
| 0.046 | 0.045 | 0.046 | Sodium/calcium exchanger inhibitor | |||
| 0.081 | 0.081 | 0.088 | Aminopeptidase B inhibitor | 0.088 0.075 DBMET00940 | DBMET00940 | |
| 0.03 | 0.029 | 0.03 | Growth hormone secretagogue receptor antagonist | |||
| 0.152 | 0.153 | 0.163 | Immunostimulant | 0.163 0.144 DBMET00940 | DBMET00940 | |
| 0.009 | 0.01 | 0.012 | Melatonin 5 antagonist | 0.012 0.007 DBMET00940 | DBMET00940 | |
| 0.041 | 0.042 | 0.043 | Melanocortin antagonist | 0.043 0.038 DBMET00940 | DBMET00940 | |
| 0.01 | 0.012 | 0.015 | Melatonin 2 antagonist | 0.015 0.005 DBMET00940 | DBMET00940 | |
| 0.15 | 0.152 | 0.153 | MAP kinase kinase 5 inhibitor | 0.153 0.14 DBMET00940 | DBMET00940 | |
| 0.158 | 0.16 | 0.205 | Interleukin agonist | 0.205 0.116 DBMET00940 | DBMET00940 | |
| 0.043 | 0.046 | 0.056 | Dopamine D4 agonist | 0.056 0.03 DBMET00940 | DBMET00940 | |
| 0.083 | 0.086 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.057 DBMET00940 | DBMET00940 | |
| 0.019 | 0.023 | 0.024 | Dopamine D1 agonist | 0.024 0.014 DBMET00940 | DBMET00940 | |
| 0.072 | 0.076 | 0.121 | Inducible nitric-oxide synthase inhibitor | 0.121 0.024 DBMET00940 | DBMET00940 | |
| 0.181 | 0.186 | 0.203 | Immunomodulator | 0.203 0.161 DBMET00940 | DBMET00940 | |
| 0.094 | 0.099 | 0.105 | TRPA1 agonist | 0.105 0.079 DBMET00940 | DBMET00940 | |
| 0.03 | 0.035 | 0.045 | Melanocortin 1 antagonist | 0.045 0.022 DBMET00940 | DBMET00940 | |
| 0.084 | 0.089 | 0.116 | Falcipain 3 inhibitor | 0.116 0.057 DBMET00940 | DBMET00940 | |
| 0.105 | 0.111 | 0.181 | Histone deacetylase SIRT1 inhibitor | 0.181 0.039 DBMET00940 | DBMET00940 | |
| 0.051 | 0.057 | 0.059 | Immunoglobulin Fc receptor antagonist | 0.059 0.027 DBMET00940 | DBMET00940 | |
| 0.025 | 0.031 | 0.03 | Dipeptidyl peptidase I inhibitor | 0.03 0.022 DBMET00940 | DBMET00940 | |
| 0.159 | 0.165 | 0.214 | Calpain inhibitor | 0.214 0.1 DBMET00940 | DBMET00940 | |
| 0.056 | 0.062 | 0.072 | Histone deacetylase inhibitor | 0.072 0.038 DBMET00940 | DBMET00940 | |
| 0.026 | 0.032 | 0.068 | Gonadotropin-releasing hormone receptor antagonist | 0.068 0.012 DBMET00940 | DBMET00940 | |
| 0.044 | 0.052 | 0.071 | Histamine agonist | 0.071 0.019 DBMET00940 | DBMET00940 | |
| 0.049 | 0.058 | 0.058 | Bombesin 1 receptor agonist | 0.058 0.044 DBMET00940 | DBMET00940 | |
| 0.031 | 0.04 | 0.044 | Histone deacetylase class I inhibitor | 0.044 0.023 DBMET00940 | DBMET00940 | |
| 0.034 | 0.047 | 0.054 | Histamine H2 receptor agonist | 0.054 0.018 DBMET00940 | DBMET00940 | |
| 0.037 | 0.049 | 0.046 | Glutamate (mGluR4) antagonist | 0.046 0.026 DBMET00940 | DBMET00940 | |
| 0.011 | 0.024 | 0.028 | Melatonin 3 antagonist | 0.028 0.009 DBMET00940 | DBMET00940 | |
| 0.054 | 0.075 | 0.067 | Histone deacetylase SIRT3 inhibitor | 0.067 0.032 DBMET00940 | DBMET00940 | |
| 0.027 | 0.05 | 0.039 | Histone deacetylase 8 inhibitor | 0.039 0.031 DBMET00940 | DBMET00940 | |
| 0.085 | 0.11 | 0.109 | Proteasome inhibitor | 0.109 0.076 DBMET00940 | DBMET00940 | |
| 0.129 | 0.156 | 0.141 | Phospholipase C inhibitor | 0.141 0.125 DBMET00940 | DBMET00940 | |
| 0.07 | 0.098 | 0.186 | Bronchodilator | 0.186 0.021 DBMET00940 | DBMET00940 | |
| 0.13 | 0.157 | 0.15 | Cyclin-dependent kinase 3 inhibitor | 0.15 0.095 DBMET00940 | DBMET00940 | |
| 0.085 | 0.118 | 0.102 | Factor V inhibitor | 0.102 0.064 DBMET00940 | DBMET00940 | |
| 0.014 | 0.05 | 0.026 | Beta 1 adrenoreceptor agonist | 0.026 0.011 DBMET00940 | DBMET00940 | |
| 0.178 | 0.215 | 0.2 | Apoptosis antagonist | 0.2 0.179 DBMET00940 | DBMET00940 | |
| 0.047 | 0.087 | 0.075 | Cannabinoid receptor antagonist | 0.075 0.045 DBMET00940 | DBMET00940 | |
| 0.082 | 0.125 | 0.112 | Nav1.5 sodium channel blocker | 0.112 0.065 DBMET00940 | DBMET00940 | |
| 0.021 | 0.064 | 0.035 | Bombesin 1 receptor antagonist | 0.035 0.029 DBMET00940 | DBMET00940 | |
| 0.039 | 0.094 | 0.058 | Cannabinoid CB1 receptor antagonist | 0.058 0.047 DBMET00940 | DBMET00940 | |
| 0.045 | 0.1 | 0.077 | Sirtuin 1 inhibitor | 0.077 0.038 DBMET00940 | DBMET00940 | |
| 0.013 | 0.072 | 0.035 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 DBMET00940 | DBMET00940 | |
| 0.1 | 0.162 | 0.131 | Growth hormone agonist | 0.131 0.106 DBMET00940 | DBMET00940 | |
| 0.032 | 0.097 | 0.064 | NMDA receptor glycine site agonist | 0.064 0.042 DBMET00940 | DBMET00940 | |
| 0.158 | 0.234 | 0.204 | Calpain 2 inhibitor | 0.204 0.184 DBMET00940 | DBMET00940 | |
| 0.069 | 0.162 | 0.09 | Glutamate (mGluR7) agonist | 0.09 0.084 DBMET00940 | DBMET00940 | |
| 0.091 | 0.192 | 0.139 | Sphingosine 1-phosphate receptor 2 antagonist | 0.139 0.057 DBMET00940 | DBMET00940 | |
| 0.044 | 0.164 | 0.071 | Carbonic anhydrase VI inhibitor | 0.071 0.07 DBMET00940 | DBMET00940 | |
| 0.059 | 0.192 | 0.094 | Carbonic anhydrase XV inhibitor | 0.094 0.077 DBMET00940 | DBMET00940 | |
| 0.087 | 0.225 | 0.151 | Insulin sensitizer | 0.151 0.132 DBMET00940 | DBMET00940 | |
| 0.081 | 0.238 | 0.153 | Insulin secretagoues | 0.153 0.071 DBMET00940 | DBMET00940 | |
| 0.048 | 0.224 | 0.102 | Histone deacetylase class III inhibitor | 0.102 0.088 DBMET00940 | DBMET00940 | |
| 0.074 | 0.253 | 0.131 | Neuropeptide Y1 antagonist | 0.131 0.098 DBMET00940 | DBMET00940 | |
| 0.02 | 0.215 | 0.049 | Myc inhibitor | 0.049 0.046 DBMET00940 | DBMET00940 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |